Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

socalTECH

JULY 16, 2013

According to Core Innovation Capital , it has moved its offices to Los Angeles from New York City, to be closer to potential investments in its focus area of funding companies serving underbanked consumers in America. core innovation capital venture investment fund' The firm''s efforts here are headed by Arjun Schutte.

Capital 174

Capital Southern California Avalon SoCalTech 174

socalTECH

JANUARY 17, 2017

AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. as early as Thursday.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

JANUARY 26, 2017

AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. Anaptys priced its IPO on Wednesday night at $15.00 per share, at the midpoint of its $14.00 estimated IPO range, and closed the day at $17.00 READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100